{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-011517","form_type":"8-K","ticker":"MBIO","cik":"0001680048","company_name":"MUSTANG BIO, INC.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.415929+00:00","generated_at":"2026-05-26T23:25:07.163667+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mustang Bio closes $8M public offering, regains Nasdaq minimum bid compliance","bullets":["Priced $8M offering of 2.66M shares (or equivalents) and Series C-1/C-2 warrants at $3.01 per unit; closed Feb 10, 2025.","Net proceeds ~$6.9M; warrants exercisable upon stockholder approval at $3.01/share.","Received Nasdaq notice of compliance with Bid Price Rule (minimum bid $1.00) after 1-for-50 reverse stock split on Jan 15.","Company believes it now meets Nasdaq equity rule ($2.5M minimum) following offering; awaiting formal determination."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-011517","json":"https://secwatch.observer/filing/0001104659-25-011517.json","markdown":"https://secwatch.observer/filing/0001104659-25-011517.md","text":"https://secwatch.observer/filing/0001104659-25-011517.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/0001104659-25-011517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/tm255743d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:25:07.163667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}